Latest GSK News & Updates

See the latest news and media coverage for GSK. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
GSK

Global biopharmaceutical company

gsk.com
Headquarters
London, United Kingdom
Company type
Public company
Number of employees
90,000+

Last updated

Latest news about GSK

Company announcements

  • GSK

    GSK CEO shares Q1 performance

    Luke Miels discusses strong Q1 results and 2026 start in a video.

  • GSK

    GSK reports strong Q1 2026 results

    Sales grew 5% CER to £7.6 billion, driven by Specialty Medicines. Core operating profit up 10%. Pipeline advances and 2026 guidance reaffirmed.

  • GSK

    GSK announces FDA acceptance for CHB treatment review

    It receives Breakthrough Therapy designation, advancing efforts to address global CHB burden.

  • GSK

    GSK announces FDA priority review for bepirovirsen

    The NDA is supported by Phase III B-Well trials showing significant functional cure rates; the FDA set the PDUFA date as 2026-10-26.

Unlock all announcements with a

Media coverage

  • Law360

    Judge Knocks Out Pfizer Partner's Vax Case Against GSK - Law360

    A Delaware federal judge on Thursday threw out a suit seeking a finding that a drug developer that partnered with Pfizer and BioNTech on their...

  • Pharmaphorum

    GSK goes all-in on CureVac's mRNA vaccines

    GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its...

  • Fierce Biotech

    GSK pens $1B deal with China's SiranBio for oligonucleotide that could reduce abdominal fat

    GSK has found another potential way to treat cardiometabolic disease with a modality close to the pharma's heart—oligonucleotides. The British drugmaker is paying $55 million...

  • Pharmaphorum

    GSK's big-ticket cancer alliance with Merck KGaA stumbles again

    Merck KGaA's bispecific cancer candidate bintrafusp alfa has failed a second clinical trial in the space of a few weeks, making GlaxoSmithKline's $4.2 billion licensing...

Unlock all articles with a

Never miss news about GSK

Track GSK and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

GSK competitors & trending companies

Browse news for competitors to GSK and other trending companies.